Strategies for prediction and early detection of atrial fibrillation: present and future

Affiliations

¹ Arrhythmia Unit, Cardiology Department, General University Hospital of Alicante, Alicante, Spain.
² Hematology and Medical Oncology Unit, Morales Meseguer University Hospital, University of Murcia, Virgen de la Arrixaca Biosanitary Investigation Institute, IMIB-Arrixaca, Murcia, Spain.
³ Department of Cardiology, Virgen de la Arrixaca University Hospital, University of Murcia, Virgen de la Arrixaca Biosanitary Investigation Institute, IMIB-Arrixaca, Ctra Madrid-Cartagena s/n, Murcia 30120, Spain.

Editorial

Amaya García-Fernández et al. Europace. 2017.

. 2017 Apr 1;19(4):515-517.

doi: 10.1093/europace/euw131.

¹ Arrhythmia Unit, Cardiology Department, General University Hospital of Alicante, Alicante, Spain.
² Hematology and Medical Oncology Unit, Morales Meseguer University Hospital, University of Murcia, Virgen de la Arrixaca Biosanitary Investigation Institute, IMIB-Arrixaca, Murcia, Spain.
³ Department of Cardiology, Virgen de la Arrixaca University Hospital, University of Murcia, Virgen de la Arrixaca Biosanitary Investigation Institute, IMIB-Arrixaca, Ctra Madrid-Cartagena s/n, Murcia 30120, Spain.

No abstract available

Comment on

CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation.
Wakula P, Neumann B, Kienemund J, Thon-Gutschi E, Stojakovic T, Manninger M, Scherr D, Scharnagl H, Kapl M, Pieske B, Heinzel FR. Wakula P, et al. Europace. 2017 Apr 1;19(4):544-551. doi: 10.1093/europace/euw101. Europace. 2017. PMID: 28431065